Contact
Please use this form to send email to PR contact of this press release:
Summary of opinion: Soliris,eculizumab, 22/06/2023, Positive
TO:
Please use this form to send email to PR contact of this press release:
Summary of opinion: Soliris,eculizumab, 22/06/2023, Positive
TO: